fever stomach pain cough
Posted by admin on 25 September, 2010
No comments yet
This item was filled under [ Most Popular ]
Novartis Gains FDA Approval For Gilenya™, A Novel First-Line Multiple Sclerosis Treatment Shown To Significantly …
Today Novartis announced that the US Food and Drug Administration (FDA) approved the oral multiple sclerosis (MS) treatment Gilenya™ (fingolimod) 0.5 mg daily, a first-line treatment for relapsing forms of multiple sclerosis – the most common forms of the disease.
The Trio – Boom Boom Pow
